Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: results of a prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples